RSS Items

The prizewinning author of ‘Assembly’ on social class, her new novel ‘Universality’ — and why she might return to working in finance

Europe’s problem banks now appear to be some of those best positioned for growth

Buyer is the controlling shareholder in Wegovy maker Novo Nordisk

Novo Nordisk’s controlling shareholder plans to allocate up to $7bn a year by 2030

Biotech acquisitions this year intended to cement position as market leaders in weight-loss field

Senator Bernie Sanders accuses Ozempic and Wegovy maker of ‘ripping off’ Americans

Danish company expects data to show that CagriSema cuts weight by 25 per cent in just over a year

Pharma group behind blockbuster drug wants to supersize its market impact

Participants with type 2 diabetes had an average weight loss of 15.7 per cent after 68 weeks on CagriSema

People treated with amycretin lost up to 22% of their body weight after 36 weeks